[Assignments of child and adolescent psychiatry in the public health office].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to F Stöckmann.
Explore the source record for details and available documents.
Serum immunoreactive trypsin (IRT) determination has been recommended as a screening test in chronic pancreatitis. Using a commercial radioimmunoassay kit (RIA--gnost Trypsin; Behring-Werke, Marburg/Lahn, FRG) the interassay coefficient of variation was 26--44% for three different test sera. Gel filtration chromatography profiles revealed immunoreactivity in the position of 125I-trypsin and (less than 50%) in the void volume. The test was evaluated in controls (n = 90), chronic relapsing pancreatitis (CRP;n = 60) and after total pancreatectomy (n = 5). In 65% of the CRP cases decreased IRT values were found, whereas during acute attacks of CRP supranormal and normal values were found. After total pancreatectomy IRT levels were undetectable. It is concluded that the sensitivity of this IRT test is limited and that the available test system needs improvement.
Plasma-immunoreactive trypsin (IRT) was measured by radioimmunoassay in 52 patients with chronic renal failure. 29 were on conservative treatment, 14 on-regular haemodialysis, and 9 on regular haemofiltration. IRT levels were elevated in those with raised plasma creatinine and there was a significant positive correlation to plasma creatinine concentrations (r = 0.853; p less than 0.001). IRT levels were not significantly altered by haemodialysis or haemofiltration. It is concluded that the kidney plays an important role in the metabolism of plasma trypsin. Since plasma IRT levels may be elevated in patients with chronic renal failure, the IRT determination may be misleading in diagnosing acute and chronic pancreatitis in the presence of kidney disease.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.